143 related articles for article (PubMed ID: 6878245)
1. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
[TBL] [Abstract][Full Text] [Related]
2. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
[No Abstract] [Full Text] [Related]
3. [Changes in cholesterol transport by lipoproteins in patients with renal insufficiency].
Pérez A; Alegre B; Panadero J; Martín L; Breto M; Cruz JM
Rev Clin Esp; 1983 Jan; 168(1):13-6. PubMed ID: 6844674
[No Abstract] [Full Text] [Related]
4. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.
Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873
[No Abstract] [Full Text] [Related]
5. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
[TBL] [Abstract][Full Text] [Related]
6. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
8. L-carnitine in haemodialysed patients. Changes in lipid pattern.
Casciani CU; Caruso U; Cravotto E; D'Iddio S; Corsi M; Pola P; Savi L; Grilli M
Arzneimittelforschung; 1982; 32(3):293-7. PubMed ID: 7200788
[TBL] [Abstract][Full Text] [Related]
9. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
[TBL] [Abstract][Full Text] [Related]
10. Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients.
Grützmacher P; Scheuermann E; Lang W
Proc Eur Dial Transplant Assoc; 1981; 18():169-75. PubMed ID: 7036147
[TBL] [Abstract][Full Text] [Related]
11. [Plasma l-carnitine in patients with chronic hemodialysis. II. Pharmacokinetics of l-carnitine and its replacement therapy in these patients].
Kudoh Y; Shoji T; Oimatsu H; Kikuchi K; Imura O; Watarai I
Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):195-202. PubMed ID: 6748336
[No Abstract] [Full Text] [Related]
12. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of carnitine loss during haemodialysis and haemofiltration.
Rumpf KW; Leschke M; Eisenhauer T; Becker K; Köthe U; Scheler F
Proc Eur Dial Transplant Assoc; 1983; 19():298-301. PubMed ID: 6878244
[TBL] [Abstract][Full Text] [Related]
14. The effect of L-carnitine on lipid metabolism in patients on chronic haemodialysis.
Yderstraede KB; Pedersen FB; Dragsholt C; Trostmann A; Laier E; Larsen HF
Nephrol Dial Transplant; 1987; 1(4):238-41. PubMed ID: 3110681
[TBL] [Abstract][Full Text] [Related]
15. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
[TBL] [Abstract][Full Text] [Related]
16. [Carnitine metabolism in chronic kidney failure].
Fiorini F; Patrone E; Castellucci A
Clin Ter; 1992 Jan; 140(1 Pt 2):31-4. PubMed ID: 1559320
[TBL] [Abstract][Full Text] [Related]
17. Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography.
Rocchi L; Feola I; Calvani M; D'Iddio S; Alfarone C; Frascarelli M
Drugs Exp Clin Res; 1986; 12(8):707-11. PubMed ID: 3757765
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
19. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.
Günal AI; Celiker H; Dönder E; Günal SY
J Nephrol; 1999; 12(1):38-40. PubMed ID: 10203002
[TBL] [Abstract][Full Text] [Related]
20. Electromyographic changes induced by oral carnitine treatment in dialysis patients.
Albertazzi A; Spisni C; Del Rosso G; Palmieri PF; Rossini PM
Proc Clin Dial Transplant Forum; 1980; 10():1-6. PubMed ID: 7346837
[No Abstract] [Full Text] [Related]
[Next] [New Search]